Angiosarcoma – Life with Disease

Go back

Angiosarcoma is a rare and aggressive cancer that begins in the cells lining blood vessels or lymphatic vessels, appearing anywhere in the body but most often on the skin of the head, neck, or breast.

Prognosis

Understanding the prognosis of angiosarcoma can be difficult and emotionally challenging. This disease carries a serious outlook, and it’s important to approach this topic with sensitivity and honesty. The expected course of the disease and survival outcomes depend heavily on several factors, and each person’s experience will be different.

Overall, angiosarcoma has a poor prognosis compared to many other cancers. The five-year survival rate ranges from approximately 30% to 38% for patients receiving treatment. This means that roughly three out of ten people diagnosed with angiosarcoma survive at least five years after diagnosis. These numbers reflect the aggressive nature of this cancer and its tendency to spread quickly to other parts of the body.

However, statistics alone don’t tell the whole story. The prognosis varies significantly depending on where the angiosarcoma is located and how advanced it is at the time of diagnosis. People who have small tumors that can be completely removed with surgery tend to have better outcomes. Early detection plays a crucial role in improving chances of survival, which is why recognizing symptoms promptly is so important.

For angiosarcoma in certain locations, the outlook is particularly challenging. Cardiac angiosarcoma, which affects the heart, often has an especially poor prognosis, sometimes measured in just a few months rather than years. Similarly, angiosarcoma of the liver may also present with very limited survival times. This is partly because these tumors are often not discovered until they have already grown large or spread to other areas.

⚠️ Important
Many patients with angiosarcoma are not diagnosed until their cancer has already spread to other parts of the body, which significantly worsens the prognosis. The most common sites of spread are the lungs, liver, and brain. This is one reason why the disease carries such a challenging outlook overall.

The stage of the disease at diagnosis is perhaps the most important factor affecting prognosis. Stage 1 and stage 2 angiosarcomas, which are smaller and have not yet spread, are considered low-grade and offer better survival chances. Stage 3 and stage 4 tumors, which have grown larger or spread to distant organs, are high-grade and carry a much more difficult prognosis. Unfortunately, because angiosarcoma can be difficult to recognize in its early stages, many people are diagnosed at more advanced stages.

Age can also influence outcomes. While angiosarcoma can occur at any age, it most commonly affects adults, particularly those aged 60 and older. The body’s ability to tolerate aggressive treatments like surgery, chemotherapy, and radiation may vary with age and overall health status.

It’s worth noting that survival rates are based on past data from groups of patients, and newer treatments are being developed that may improve outcomes. Every individual is unique, and factors such as overall health, response to treatment, and the specific characteristics of the tumor all play important roles in determining prognosis.

Natural Progression

When angiosarcoma is left untreated, it follows a particularly aggressive course. Understanding how the disease develops naturally helps explain why early intervention is so critical. The cancer does not remain static but instead grows and spreads with considerable speed.

Without treatment, angiosarcoma tumors continue to enlarge at their original site. For skin-based angiosarcomas, what may start as a small bruise-like mark or reddish lump will expand over time. The area may begin to bleed easily when bumped or scratched, and the discoloration can spread across a wider area of skin. The tumor can break through the skin surface, creating open sores that don’t heal and may become infected.

The most dangerous aspect of untreated angiosarcoma is its high tendency to spread beyond its original location. Because these tumors originate from blood vessel or lymphatic vessel cells, cancer cells have direct access to the body’s circulatory system. This makes it remarkably easy for the disease to travel to distant organs. The lungs and liver are the most common destinations for metastasis (the spread of cancer from one organ to another), though the cancer can also reach the brain, bones, and other tissues.

As the disease progresses and spreads, symptoms become more severe and debilitating. People may experience increasing pain in affected areas, persistent fatigue that doesn’t improve with rest, and unexplained weight loss. If the cancer spreads to the lungs, breathing becomes increasingly difficult. Liver involvement can cause yellowing of the skin and eyes, a condition called jaundice, along with abdominal swelling and pain.

For angiosarcoma developing in internal organs like the heart or liver, the natural progression can be particularly rapid and devastating. These tumors may grow silently for some time before causing noticeable symptoms. By the time symptoms appear, the tumor is often quite large and may have already spread. In cardiac angiosarcoma, the tumor can interfere with the heart’s ability to pump blood effectively, leading to heart failure.

The timeline of untreated angiosarcoma progression varies, but it is generally measured in months rather than years. The aggressive nature of this cancer means that without intervention, the disease advances quickly, overwhelming the body’s normal functions and ultimately proving fatal.

Possible Complications

Angiosarcoma can lead to various complications, both from the disease itself and, in some cases, from its treatment. These complications can significantly impact a person’s health and quality of life, making their management an important part of care.

One of the most common complications is local tissue damage and destruction. As angiosarcoma grows, it invades and destroys surrounding healthy tissues. For skin angiosarcomas, particularly those on the scalp or face, this can result in significant disfigurement. The tumor may erode through the skin, creating wounds that bleed easily and are prone to infection. These open lesions can be painful, difficult to care for, and may emit unpleasant odors, affecting a person’s self-image and social interactions.

Bleeding is another frequent complication. Because angiosarcoma involves blood vessels, these tumors are highly vascular (containing many blood vessels) and can bleed spontaneously or with minimal trauma. Even small bumps or scratches can trigger significant bleeding that may be difficult to control. In severe cases, internal bleeding from tumors in organs like the liver or heart can be life-threatening and require emergency medical intervention.

When angiosarcoma affects the heart, specific cardiac complications arise. The tumor can block blood flow through the heart chambers or interfere with the heart valves’ ability to function properly. This can lead to heart failure, a condition where the heart cannot pump enough blood to meet the body’s needs, causing shortness of breath, fluid buildup in the legs and lungs, and extreme fatigue. Another serious cardiac complication is cardiac tamponade, where fluid accumulates around the heart, compressing it and preventing it from filling and pumping properly. This is a medical emergency requiring immediate treatment.

Abnormal heart rhythms, called arrhythmias, can also develop when cardiac tissue is affected by the tumor. These irregular heartbeats can range from merely uncomfortable palpitations to life-threatening rhythms that prevent the heart from functioning effectively.

The spread of angiosarcoma to other organs creates organ-specific complications. When the cancer reaches the lungs, it can cause persistent coughing, shortness of breath, and chest pain. Lung metastases may also lead to the accumulation of fluid around the lungs, further compromising breathing. Liver involvement can result in jaundice, abdominal pain and swelling, and impaired liver function, which affects the body’s ability to process nutrients and eliminate toxins. Brain metastases can cause headaches, seizures, changes in behavior or personality, and neurological deficits.

People with angiosarcoma may develop anemia (low red blood cell count), either from chronic bleeding from the tumor or as a side effect of treatment. Anemia causes fatigue, weakness, dizziness, and shortness of breath, significantly reducing a person’s ability to carry out daily activities.

Another complication is the formation of blood clots. Cancer, particularly aggressive cancers like angiosarcoma, can increase the risk of developing clots in the legs or lungs. These clots can be dangerous, potentially blocking blood flow and causing serious health emergencies.

Following surgery, complications can include infection, delayed wound healing, and loss of function in the affected area. For instance, surgery on the limbs might require extensive tissue removal, potentially affecting mobility and strength. Breast angiosarcoma treatment typically requires complete removal of the breast, which carries its own set of physical and emotional challenges.

Impact on Daily Life

Living with angiosarcoma affects nearly every aspect of daily life, from physical abilities to emotional well-being and social relationships. The impact varies depending on the tumor’s location, the stage of disease, and the treatments being received, but most people face significant changes to their normal routines.

Physically, angiosarcoma and its treatments can be exhausting. Many people experience profound fatigue that doesn’t improve with rest. Simple tasks like getting dressed, preparing meals, or walking short distances may become difficult or impossible. This fatigue is often compounded by anemia, pain, and the general strain that cancer places on the body. People undergoing chemotherapy may face additional physical challenges, including nausea, loss of appetite, hair loss, and increased susceptibility to infections.

Pain management becomes a daily concern for many. The tumor itself can cause pain, particularly as it grows and presses on surrounding tissues or nerves. Following surgery, there may be surgical pain and discomfort during the healing process. Some people require regular pain medication, which must be carefully managed to provide relief while minimizing side effects that can include drowsiness, constipation, and confusion.

For angiosarcoma affecting visible areas like the scalp, face, or neck, changes in appearance can be particularly distressing. The tumor may create noticeable discoloration, swelling, or lesions. Hair loss from the tumor itself or from treatment can affect self-image. Some people feel self-conscious in social situations and may withdraw from activities they once enjoyed. Wearing wigs, scarves, or special makeup can help, but adjusting to a changed appearance takes time and emotional resilience.

Work life is often significantly disrupted. The disease and its treatment may make it impossible to maintain regular work schedules. Frequent medical appointments, hospitalizations, and periods of feeling too unwell to work can lead to reduced income and concerns about job security. Some people must take extended medical leave or even stop working entirely, which adds financial stress to an already difficult situation.

Daily activities and hobbies may need to be modified or abandoned. Physical activities like sports or exercise may be limited by fatigue, pain, or physical limitations from surgery. Even gentle activities like gardening or crafts might become challenging. Finding new, adapted ways to stay engaged and maintain quality of life becomes important but can be frustrating.

Emotionally, angiosarcoma carries a heavy burden. Learning about the poor prognosis can trigger fear, anxiety, and depression. Worries about the future, concerns about loved ones, and the stress of navigating complex medical decisions create ongoing emotional strain. Many people experience mood swings, difficulty concentrating, and sleep disturbances. Feelings of grief about lost abilities, changed appearance, and uncertain future are common and completely normal.

Relationships with family and friends often shift. Loved ones may struggle with their own fears and not know how to provide support. Some people feel isolated because others don’t understand what they’re going through. At the same time, many find that their relationships deepen as they learn to communicate more openly about fears and needs. Accepting help from others can be difficult for those who are used to being independent, but it becomes necessary.

Intimacy and sexuality may be affected by physical changes, fatigue, pain, and emotional distress. Partners may need to find new ways to maintain closeness and connection. Open communication about needs and concerns becomes essential but can feel awkward or difficult.

Managing the practical aspects of life with angiosarcoma requires organization and planning. Keeping track of multiple medications, managing appointment schedules, dealing with insurance issues, and organizing medical records becomes almost like a part-time job. Many people benefit from having a family member or friend help coordinate care.

Despite these challenges, many people find ways to cope and maintain meaning in their lives. Some find comfort in support groups where they can connect with others facing similar experiences. Others focus on staying as active as possible within their limitations, finding new interests or rekindling old ones in adapted forms. Spending quality time with loved ones often becomes a priority. Some people find that their experience with cancer gives them a different perspective on what matters most in life.

Support for Family

When a loved one faces angiosarcoma, family members and friends play a crucial role in providing support, especially when considering participation in clinical trials. Understanding what clinical trials are and how families can help their loved one navigate this option is an important part of the journey.

Clinical trials are research studies that test new treatments, new combinations of treatments, or new approaches to using existing treatments. For rare and aggressive cancers like angiosarcoma, clinical trials may offer access to cutting-edge therapies that are not yet widely available. Because angiosarcoma is so rare and standard treatments have limited effectiveness, doctors may recommend considering clinical trial participation as part of the treatment plan.

Families should understand that participating in a clinical trial doesn’t mean giving up on treatment or being used as a “guinea pig.” These studies are carefully designed and monitored to protect participants while gathering important information about new treatments. Every clinical trial has strict eligibility requirements, and not every patient will qualify for every trial. The trial might be testing new medications, combinations of existing drugs, novel radiation techniques, or immunotherapy approaches.

One of the most valuable ways family members can help is by researching clinical trial options. Major cancer centers often have lists of currently enrolling trials for angiosarcoma. Websites like ClinicalTrials.gov provide searchable databases of studies happening across the country and around the world. Family members can take on the task of searching these databases, reading about different trials, and compiling a list of potentially suitable options to discuss with the patient’s medical team.

When researching trials, families should pay attention to the eligibility criteria. These specify exactly what characteristics a patient must have to participate, such as the stage of disease, previous treatments received, age, and overall health status. Understanding these requirements helps narrow down which trials might be appropriate before investing time in lengthy application processes.

Location is another important consideration. Some trials are only available at specific research institutions, which might be far from home. Families can help by investigating the practical aspects of trial participation, such as how often visits would be required, whether travel assistance or accommodation support is available, and whether local doctors can coordinate some aspects of care to reduce travel burden.

Supporting a loved one through the decision-making process about trial participation is crucial. This decision can feel overwhelming, and having family members who can help weigh the potential benefits against the possible risks and inconveniences is valuable. Families should attend medical appointments when possible, take notes, and help prepare lists of questions to ask the research team. Questions might include: What is the goal of this trial? What are the potential side effects? What happens if the treatment doesn’t work? Will there be any costs to the patient?

Once enrolled in a trial, family members can provide practical support by helping manage the increased demands of participation. Clinical trials often require more frequent visits, additional tests, and detailed record-keeping. Families can assist with transportation to appointments, help track side effects and symptoms that need to be reported, ensure medications are taken as prescribed, and maintain organized records of all trial-related information.

Emotional support during trial participation is equally important. The uncertainty of whether a treatment will work, combined with possible side effects from experimental therapies, can be stressful. Family members can provide encouragement, celebrate small victories, and offer comfort during setbacks. Simply being present and willing to listen makes a significant difference.

Families should also be prepared for the possibility that a trial might not work out as hoped. The patient might not qualify after initial screening, or the treatment might not be effective. Sometimes side effects require discontinuing participation. Having honest conversations about backup plans and next steps helps everyone feel more prepared for different outcomes.

Communication with the broader family and friend network is another area where support is needed. Helping the patient decide what information to share, when, and with whom can relieve some of the burden of constantly updating everyone about their condition and treatment. Some families find that designating one person as the main communicator, or using online platforms to share updates, works well.

Financial and practical support matters too. Clinical trials typically cover the cost of the experimental treatment itself, but there may be costs for travel, accommodation, meals, and time away from work. Family members can help by coordinating fundraising efforts if needed, researching financial assistance programs, or providing direct financial support when possible.

⚠️ Important
Families should remember to take care of their own physical and emotional health while supporting a loved one with angiosarcoma. Caregiver burnout is real, and maintaining your own well-being enables you to provide better support over the long term. Don’t hesitate to seek help from other family members, friends, or professional counselors when needed.

Connecting with advocacy organizations focused on sarcoma or cancer in general can provide families with additional resources and support. These organizations often have information about clinical trials, can help navigate the healthcare system, and provide communities where families can connect with others facing similar challenges. Some offer patient navigation services that help families understand their options and make informed decisions.

Finally, families should recognize that their loved one has the right to make their own decisions about treatment, including whether to participate in clinical trials. The family’s role is to support, inform, and advocate, but ultimately to respect the patient’s choices about their own care. Creating an environment where the patient feels empowered to make decisions while knowing they have unwavering family support is perhaps the most important thing families can do.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Paclitaxel – A chemotherapy drug particularly effective for angiosarcoma, often administered weekly as a single agent
  • Doxorubicin – An anthracycline-based chemotherapy drug commonly used as part of treatment regimens for angiosarcoma
  • Pazopanib – A targeted therapy drug that inhibits vascular endothelial growth factor receptors, used in advanced vascular sarcomas
  • Gemcitabine – A chemotherapy drug often used in combination regimens with other agents like docetaxel, vinorelbine, or dacarbazine
  • Propranolol – A beta-blocker that has shown effectiveness in some patients with advanced angiosarcoma when combined with other medications
  • Epirubicin – An anthracycline chemotherapy drug used in treatment regimens for angiosarcoma

Ongoing Clinical Trials on Angiosarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated drugs:
    Germany
  • Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Denmark Norway Sweden

References

https://www.mayoclinic.org/diseases-conditions/angiosarcoma/symptoms-causes/syc-20350244

https://en.wikipedia.org/wiki/Angiosarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC10622948/

https://www.childrenshospital.org/conditions/angiosarcoma

https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/types/angiosarcoma

https://www.ahn.org/services/cancer/types/angiosarcoma

https://sarcoma.org.uk/about-sarcoma/what-is-sarcoma/types-of-sarcoma/angiosarcoma/

https://www.webmd.com/cancer/what-is-angiosarcoma

https://my.clevelandclinic.org/health/diseases/cardiac-angiosarcoma

https://pmc.ncbi.nlm.nih.gov/articles/PMC6895451/

https://www.mayoclinic.org/diseases-conditions/angiosarcoma/diagnosis-treatment/drc-20350248

https://emedicine.medscape.com/article/276512-treatment

https://www.ncbi.nlm.nih.gov/books/NBK441983/

https://my.clevelandclinic.org/health/diseases/22778-angiosarcoma

https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma/types/angiosarcoma

https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors/angiosarcoma

https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v4n2/14-plichta-primary-angiosarcoma-of-breast/

https://www.mdanderson.org/cancerwise/angiosarcoma-survivo.h00-159063978.html

https://my.clevelandclinic.org/health/diseases/22778-angiosarcoma

https://www.news-medical.net/health/Support-for-Angiosarcoma.aspx

https://www.cureasc.org/what-is-angiosarcoma/

https://www.mdanderson.org/cancerwise/young-adult-angiosarcoma-survivor–why-i-went-to-md-anderson-for-cancer-treatment.h00-159776445.html

https://www.ahn.org/services/cancer/types/angiosarcoma

https://www.mayoclinic.org/diseases-conditions/angiosarcoma/diagnosis-treatment/drc-20350248

https://www.smartpatients.com/communities/angiosarcoma

https://sarcoma.org.uk/about-sarcoma/what-is-sarcoma/types-of-sarcoma/angiosarcoma/

FAQ

Can angiosarcoma be cured?

Early-stage angiosarcoma that is completely removed with surgery offers the best chance for long-term survival, though the disease has a high rate of recurrence. Complete cure is possible in some cases when the tumor is small, localized, and caught early, but the aggressive nature of this cancer makes long-term survival challenging. The five-year survival rate is approximately 30-38% overall.

What does angiosarcoma look like on the skin?

Angiosarcoma on the skin typically appears as a raised area that looks like a bruise, often purple, reddish, or blue in color. It may start small but grows larger over time and can bleed easily when scratched or bumped. The lesion doesn’t fade like a normal bruise would and may be accompanied by swelling in the surrounding skin.

Why is angiosarcoma so aggressive?

Angiosarcoma is aggressive because it originates from cells lining blood vessels or lymphatic vessels, giving cancer cells direct access to the body’s circulatory system. This makes it extremely easy for the disease to spread to distant organs like the lungs, liver, and brain. The cancer is considered high-grade by definition, meaning it grows and spreads rapidly.

Who is most likely to get angiosarcoma?

Angiosarcoma most commonly affects elderly white men, particularly those aged 60-70, though it can occur at any age. People who have received radiation therapy (especially for breast cancer), those with chronic lymphedema, and individuals exposed to certain chemicals like vinyl chloride, arsenic, or thorium dioxide have an increased risk. Some genetic conditions also raise the risk.

How is angiosarcoma different from other types of cancer?

Angiosarcoma differs from other cancers in that it arises specifically from the endothelial cells that line blood or lymphatic vessels, rather than from organ tissues. It’s classified as a soft tissue sarcoma, which is already a rare category, and angiosarcoma makes up only 1-2% of all sarcomas. Its aggressive behavior and high tendency to spread early make it particularly challenging to treat compared to many other cancer types.

🎯 Key Takeaways

  • Angiosarcoma affects only about 1 person per million each year in the United States, making it an extraordinarily rare cancer
  • The disease can appear anywhere in the body but shows a particular preference for the scalp, face, neck, and breast
  • Early detection dramatically improves outcomes, yet many cases aren’t discovered until the cancer has already spread
  • Radiation therapy received years earlier for another cancer can trigger angiosarcoma development, typically 8-10 years after treatment
  • What looks like a simple bruise that doesn’t fade could be the first sign of skin angiosarcoma
  • Treatment almost always requires a combination approach including surgery, chemotherapy, and radiation rather than just one method
  • Clinical trials may offer access to newer treatments for this rare cancer, since standard therapies have limited effectiveness
  • Family support becomes essential not just emotionally but practically, especially when navigating complex treatment decisions and clinical trial options